# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4540359 | 97 | Activity | = | 18 | % | ALA4397139 | % | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | |||
2. | ALA4540359 | 97 | EC50 | = | 13 | uM | ALA4397106 | 4.89 | nM | |||
3. | ALA4540359 | 97 | EC50 | = | 10 | uM | ALA4397105 | 5.00 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | ||
4. | ALA4540359 | 97 | Activity | = | 21 | % | ALA4397101 | % | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | |||
5. | ALA4540359 | 97 | CC50 | = | 20 | uM | ALA4397096 | nM | Homo sapiens | |||
6. | ALA4540359 | 97 | CC50 | = | 2.7 | uM | ALA4397095 | nM | Homo sapiens | |||
7. | ALA4540359 | 97 | CLH | = | 78 | microL/min/mg | ALA4397094 | mL.min-1.g-1 | ||||
8. | ALA4540359 | 97 | t1/2 | = | 22 | min | ALA4397093 | hr | ||||
9. | ALA4540359 | 97 | CLH | = | 30 | microL/min/mg | ALA4397092 | mL.min-1.g-1 | ||||
10. | ALA4540359 | 97 | t1/2 | = | 58 | min | ALA4397091 | hr | ||||
11. | ALA4540359 | 97 | solubility | < | 1.6 | uM | ALA4397090 | nM | ||||
12. | ALA4540359 | 97 | solubility | < | 1.6 | uM | ALA4397089 | nM | ||||
13. | ALA4540359 | 97 | EC50 | = | 15 | uM | ALA4397085 | 4.82 | nM | Homo sapiens | ||
14. | ALA4540359 | 97 | EC50 | = | 2.2 | uM | ALA4397086 | 5.66 | nM | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) |